Filtered By:
Therapy: Neoadjuvant Therapy
Countries: Italy Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 43 results found since Jan 2013.

The Impact of COVID19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center In Italy
CONCLUSIONS: There was no evidence for major changes in the management of patients with EBC during 2019-2021 and no treatment delays were observed. Our findings suggest that more women presented with palpable nodules at diagnosis, but the stage distribution did not change over time. Validation on a larger cohort of patients is warranted to robustly assess the impact of the COVID19 pandemic on treatment practices for patients with EBC.PMID:37699107 | DOI:10.1093/oncolo/oyad255
Source: The Oncologist - September 12, 2023 Category: Cancer & Oncology Authors: Fabio Girardi Sabrina Marini Francesca Porra Sonia Carpentieri Alberto Marchet Tania Saibene Marcello Lo Mele Tommaso Giarratano Carlo Alberto Giorgi Eleonora Mioranza Cristina Falci Giovanni Faggioni Francesca Caumo Gaia Griguolo Maria Vittoria Dieci Val Source Type: research

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
CONCLUSION: Our findings suggested that TPC combination could be a cost-saving option in patients with HER2+BC at high-risk of recurrence.PMID:37573652 | DOI:10.1016/j.breast.2023.08.005
Source: Breast - August 13, 2023 Category: Cancer & Oncology Authors: Alberto Zambelli Marina Cazzaniga Nicla La Verde Elisabetta Munzone Ippazio Cosimo Antonazzo Lorenzo Giovanni Mantovani Serena Di Cosimo Anna Mancuso Daniele Generali Paolo Angelo Cortesi Source Type: research

Therapy delay due to COVID-19 pandemic among European women with breast cancer: prevalence and associated factors
CONCLUSION: Addressing factors associated with therapy delays, such as patient performance status, treatment settings, and geographic location, can help guide strategies for improved BC care delivery in the future.PMID:37405476 | DOI:10.1007/s00432-023-05065-7
Source: Clinical Breast Cancer - July 5, 2023 Category: Cancer & Oncology Authors: Niklas Gremke Sebastian Griewing Elena Bausch Svetlana Alymova Uwe Wagner Karel Kostev Matthias Kalder Source Type: research